Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy-Reference-Cited by-同舟云学术

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

Published:2007-04 Issue:4 Volume:18 Page:694-700
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Wilking N.,Lidbrink E.,Wiklund T.,Erikstein B.,Lindman H.,Malmström P.,Kellokumpu-Lehtinen P.,Bengtsson N-O,Söderlund G.,Anker G.,Wist E.,Ottosson S.,Salminen E.,Ljungman P.,Holte H.,Nilsson J.,Blomqvist C.,Bergh J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/4/694/309180/mdl488.pdf

Reference36 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;EBCTCG;Lancet,2005

2. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials;Clarke;Lancet,2005

3. Cytotoxic and hormonal treatment for metastatic breast cancer: a systemic review of published randomized trial involving 31,510 women;Fossati;J Clin Oncol,1998

4. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial;French Adjuvant Study Group;J Clin Oncol,2001

5. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22;Fisher;J Clin Oncol,1997

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer;Clinical Breast Cancer;2021-10

2. Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy;Clinical Breast Cancer;2021-06

3. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes;JAMA Oncology;2020-04-01

4. The rationale of dose–response curves in selecting cancer drug dosing;British Journal of Clinical Pharmacology;2019-06-20

5. A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1);European Journal of Cancer;2018-05